Tazemetostat

From WikiMD.org
Jump to navigation Jump to search

Tazemetostat

Tazemetostat (pronounced ta-zuh-ME-toh-stat) is a medication used in the treatment of certain types of cancer. It is an enzyme inhibitor that works by blocking the activity of a specific enzyme known as EZH2.

Etymology

The name "Tazemetostat" is derived from the drug's chemical structure and its mechanism of action. The prefix "Taz" is an abbreviation of the chemical name, while "metostat" refers to the drug's ability to inhibit the EZH2 enzyme.

Usage

Tazemetostat is used in the treatment of Epithelioid Sarcoma, a rare type of soft tissue sarcoma, and certain types of Non-Hodgkin Lymphoma. It is usually given after other treatments have failed.

Side Effects

Common side effects of Tazemetostat include fatigue, nausea, vomiting, constipation, and decreased appetite. More serious side effects can include lung problems, serious infections, and an increased risk of secondary malignancies.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski